Novel nucleoside triphosphate transporter and uses thereof

US2020277342A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020277342-A1
Application numberUS-202016839741-A
CountryUS
Kind codeA1
Filing dateApr 3, 2020
Priority dateJun 24, 2016
Publication dateSep 3, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum. Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of increasing production of a nucleic acid molecule in a cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural nucleoside triphosphates, and (c) transporting the one or more unnatural nucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter. 2 . The method of claim 1 , wherein the nucleic acid molecule comprises DNA. 3 . The method of claim 1 , wherein the nucleic acid molecule comprises RNA. 4 . The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 5 . The method of claim 1 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 6 . The method of claim 1 , wherein the deletion is a N-terminal deletion. 7 . The method of claim 1 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4. 8 . The method of claim 1 , wherein the cell is an engineered cell. 9 . The method of claim 8 , wherein the engineered cell is E. coli. 10 . The method of claim 1 , wherein the cell is a prokaryotic cell. 11 . The method of claim 10 , wherein the cell is E. coli. 12 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base selected from the group consisting of 13 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 14 . The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is 15 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from the group consisting of 16 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 17 . The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is 18 . A method of increasing production of a DNA nucleic acid molecule in a cell comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural 2′-deoxyribonucleoside triphosphates, and (c) transporting the one or more unnatural 2′-deoxyribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprise a base selected from the group consisting of: 19 . The method of claim 18 , wherein the cell is E. coli. 20 . The method of claim 18 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 21 . The method of claim 18 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 22 . The method of claim 18 , wherein the deletion is a N-terminal deletion. 23 . The method of claim 18 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4. 24 . A method of increasing production of a RNA nucleic acid molecule in a cell, comprising: (a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion, (b) incubating the cell with one or more unnatural ribonucleoside triphosphates, and (c) transporting the one or more unnatural ribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural ribonucleoside triphosphates comprise a base selected from the group consisting of: 25 . The method of claim 24 , wherein the cell is E. coli. 26 . The method of claim 24 , wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum. 27 . The method of claim 24 , wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues. 28 . The method of claim 24 , wherein the deletion is a N-terminal deletion. 29 . The method of claim 24 , wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4.

Assignees

Inventors

Classifications

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • C07K14/405Primary

    from algae · CPC title

  • Stable introduction of foreign DNA into chromosome · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

  • Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020277342A1 cover?
Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum. Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporte…
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07K14/405. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).